Adial Pharmaceuticals, Inc.

NasdaqCM ADIL

Adial Pharmaceuticals, Inc. Share Price on January 14, 2025: USD 1.02

Adial Pharmaceuticals, Inc. Share Price is USD 1.02 on January 14, 2025, a -31.54% change year over year. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance.

Adial Pharmaceuticals, Inc. 52-week high Share Price is USD 3.26 on March 01, 2024, which is 219.61% above the current Share Price.
Adial Pharmaceuticals, Inc. 52-week low Share Price is USD 0.82 on February 26, 2024, which is -19.60% below the current Share Price.
Adial Pharmaceuticals, Inc. average Share Price for the last 52 weeks is USD 1.25.

Key data

Date	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)

NasdaqCM: ADIL

Adial Pharmaceuticals, Inc.

CEO	Mr. Cary John Claiborne MBA
IPO Date	July 27, 2018
Location	United States
Headquarters	1180 Seminole Trail
Employees	4
Sector	Health Care
Industries Pharmaceuticals Biotechnology Clinical Trials

Description

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia.

Key trends

Past 5 years